Non-transferrin-bound iron and cellular toxicity: Editorial

Journal of Gastroenterology and Hepatology (Australia)

Volumn 14, Issue 2, 1999, Pages 105-108

  Anderson, G J ^a  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

IRON; TRANSFERRIN;

CYTOTOXICITY; EDITORIAL; ELECTRON TRANSPORT; HUMAN; IRON OVERLOAD; LIVER TOXICITY; PRIORITY JOURNAL;

EID: 0032963997     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.1999.01828.x     Document Type: Editorial

References (26)

1. 1 McNamara L, MacPhail AP, Mandishona E et al. Non‐transferrin‐bound iron and hepatic dysfunction in African dietary iron overload. J. Gastroenterol. Hepatol. 1999 ; 14: 126–132.
2. 2 Singh S, Hider RC, Porter JB. A direct method for quantification of non‐transferrin‐bound iron. Anal. Biochem. 1990 ; 186: 320–3.
3. 3 Simpson RJ, Cooper CE, Raja KB et al. Non‐transferrin‐bound iron species in the serum of hypotransferrinaemic mice. Biochim. Biophys. Acta 1992 ; 1156: 19–26.
4. 4 Grootveld M, Bell JD, Halliwell B, Aruoma OI, Bomford A, Sadler PJ. Non‐transferrin‐bound iron in plasma or serum from patients with idiopathic hemochromatosis. Characterization by high performance liquid chromatography and nuclear magnetic resonance spectroscopy. J. Biol. Chem. 1989 ; 264: 4417–22.
5. 5 Batey RG, Lai Chung Fong P, Shamir S, Sherlock S. A non‐transferrin‐bound serum iron in idiopathic hemochromatosis. Dig. Dis. Sci. 1980 ; 25: 340–6.
6. 6 Edwards CQ, Griffen LM, Kaplan J, Kushner JP. Twenty‐four hour variation of transferrin saturation in treated and untreated haemochromatosis homozygotes. J. Intern. Med. 1989 ; 226: 373–9.
7. 7 Porter Abeysinghe RD, Marshall L, Hider RC, Singh S. Kinetics of removal and reappearance of non‐transferrin‐bound plasma iron with deferoxamine therapy. Blood 1996 ; 88: 705–13.
8. 8 Wang WC, Ahmed N, Hanna M. Non‐transferrin‐bound iron in long‐term transfusion in children with congenital anemias. J. Pediatr. 1986 ; 108: 552–7.
9. 9 Hershko C, Graham G, Bates GW, Rachmilewitz EA. Non‐specific serum iron in thalassaemia: An abnormal serum iron fraction of potential toxicity. Br. J. Haematol. 1978 ; 40: 255–63.
10. 10 Bernstein SE. Hereditary hypotransferrinemia with hemosiderosis, a murine disorder resembling human atransferrinemia. J. Lab. Clin. Med. 1987 ; 110: 690–705.
11. 11 Hamill RL, Woods JC, Cook BA. Congenital atransferrinemia. A case report and review of the literature. Am. J. Clin. Pathol. 1991 ; 96: 215–18.
12. 12 Bradley SJ, Gosriwitana I, Srichairatanakool S, Hider RC, Porter JB. Non‐transferrin‐bound iron induced by myeloablative chemotherapy. Br. J. Haematol. 1997 ; 99: 337–43.
13. 13 Wheby MS & Jones JG. Role of transferrin in iron absorption. J. Clin. Invest. 1963 ; 42: 1007–16.
14. 14 Zimelman AP, Zimmerman HJ, McLean R, Weintraub LR. Effect of iron saturation of transferrin on hepatic iron uptake: An in vitro study. Gastroenterology 1977 ; 72: 129–31.
15. 15 Craven CM, Alexander J, Eldridge M, Kushner JP, Bernstein S, Kaplan J. Tissue distribution and clearance kinetics of non‐transferrin‐bound iron in the hypotransferrinemic mouse: A rodent model for hemochromatosis. Proc. Natl Acad. Sci. USA 1987 ; 84: 3457–61.
16. 16 Sciot R, Paterson AC, Van den Oord JJ, Desmet VJ. Lack of hepatic transferrin receptor expression in hemochromatosis. Hepatology 1987 ; 7: 831–7.
17. 17 Wright TL, Brissot P, Ma WL, Weisiger RA. Characterization of non‐transferrin‐bound iron clearance by rat liver. J. Biol. Chem. 1986 ; 261: 10 909–14.
18. 18 Brissot P, Wright TL, Ma WL, Weisiger RA. Efficient clearance of non‐transferrin‐bound iron by rat liver. Implications for hepatic iron loading in iron overload states. J. Clin. Invest. 1985 ; 76: 1463–70.
19. 19 Wright TL, Fitz JG, Weisiger RA. Non‐transferrin‐bound iron uptake by rat liver. Role of membrane potential difference. J. Biol. Chem. 1988 ; 263: 1842–7.
20. 20 De Silva D, Askwith C, Kaplan J. Molecular mechanisms of iron uptake in eukaryotes. Physiol. Rev. 1996 ; 76: 31–47.
21. 21 Fleming MD, Trenor CC, Su MA et al. Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transport gene. Nat. Genet. 1997 ; 16: 383–6.
22. 22 Gutierrez JA, Yu J, Rivera S, Wessling‐Resnick M. Functional expression cloning and characterization of SFT, a stimulator of Fe transport. J.Cell Biol. 1997 ; 139: 895–905.
23. 23 Halliwell B & Gutteridge JMC. Role of free radicals and catalytic metal ions in human disease: An overview. Meth. Enzymol. 1990 ; 186: 1–85.
24. 24 Britton RS, Tavill AS, Bacon BR. Mechanisms of iron toxicity. In: Brock JH, Halliday JW, Pippard MJ, Powell LW, eds. Iron Metabolism in Health and Disease. London: WB Saunders Co. Ltd, 1994; 311–51.
25. 25 Nielsen P, Dullmann J, Wulfhekel U, Heinrich HC. Non‐transferrin‐bound‐iron in serum and low‐molecular‐weight‐iron in the liver of dietary iron‐loaded rats. Int. J. Biochem. 1993 ; 25: 223–32.
26. 26 Gutteridge JMC, Rowley DA, Griffiths E, Halliwell B. Low‐molecular weight iron complexes and oxygen radical reactions in idiopathic haemochromatosis. Clin. Sci. 1985 ; 68: 463–7.